cost effectiveness, page-2

Results

In spite of a higher procedure cost, the total costs for a cohort of 100 patients associated to the CLE-based strategy were 89,313.29 € compared to 90,658.90 € for the standard strategy. The cost per patient adequately diagnosed and treated was also inferior for the CLE-based strategy (960.36 € vs. 1,054.17 €). Different sensitivity analyses (including a Monte-Carlo modeling) were performed which confirmed the robustness of previous results.

It's nice that this study comes down in favour of CLE, if only just. 89K or 91K that's less than 2% difference.

Not sure that it's good science though, to report figures down to the cent, thereby implying great precision. The variance must be huge given a small sample and large average cost per patient.
If the outcome is this close I personally wouldn't spend the extra on CLE up front.

I'm way over invested in Optiscan so believe me love to hear a good news but this one just doesn't sound so strong.

Thanks for sharing gmutton - you are the best news source we have.